Intel Sinks Even as HSBC Sees 60% Upside for Foundry
Intel shares slipped about 6% in midday trading as HSBC boosted its price target 60% higher, while AMD and the broade...
Which Is More Suitable For Aggressive Investors Index Fund Vs Target Date
Which Is More Suitable For Aggressive Investors Index Fund Vs Target Date weighs volatility, potential upside, and suitability for growth-focused plans.
28,574 articlesThis Portfolio Lets Earn Big Income Without Law School
Investors are increasingly turning to a dividend-focused portfolio to generate six-figure annual income with multi-mi...
Blowout Jobs Numbers Just Upend Warsh Plan Trump Showdown
A blowout jobs numbers just print has analysts rethinking Fed timing and a potential clash between policy and politic...
Bitcoin’s Calm Price Action Faces ETF Demand Fatigue
Bitcoin’s calm price action has persisted through February 2026, but traders warn the lull may be masking fading ETF ...
HSBC Just Upgraded Cisco: AI Revenue Push Reframes Growth
HSBC upgraded Cisco to Buy and lifted the price target as the company moves toward a $6 billion AI revenue goal for F...
Accenture: A Strong Contender in Consulting Investing
Accenture stands out as a strong contender in the consulting arena. This article digs into why investors should pay a...
G7 Confronts Making China Elephant Room in AI and Energy
As global markets digest a dual threat from US AI policy and China's energy choke points, the G7 confronts a politica...
Tungsten Surges: Is It the Next Silver Supercycle Trade?
Tungsten is hitting multi-year highs amid a tightening supply chain and rising demand from AI data centers, EV batter...
Left 40-Year Career, Claimed Social Security at 62: Worth It
A four-decade veteran leaves the daily grind to claim Social Security at 62, choosing time over a larger paycheck for...
What’s Going with Palantir Stock: An Investor's Guide
Palantir stock has captured attention as market conditions shift and AI headlines rise. This guide breaks down what’s...
Risks Investors Should Watch with CoreWeave: 3-Year View
As AI infrastructure expands, CoreWeave sits at a pivotal point. This guide identifies three key risks investors shou...
Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status